StockCIK 2019410

Caris Life Sciences, Inc. (CAI): Insider Trades and Fund Holdings

In the past 12 months, Caris Life Sciences, Inc. insiders reported 0 open-market purchases worth $0 and 4 sales worth $27.2M; 0 of the sales were reported as made under a 10b5-1 trading plan.

0Insider buys, 12 months

$0Bought by insiders, 12 months

$27.2MSold by insiders, 12 months

3Tracked funds holding

Recent insider trades

Open-market purchases (code P) and sales (code S) from Form 4. Grants, option exercises and gifts are not shown. Latest filing: Sep 23, 2026.

Recent CAI insider trades
Filed	Traded	Insider	Role	Type	Shares	Price ($)	Value	Holding	Filing
Sep 23	Sep 22	John Russel DentonSee Remarks	See Remarks	▼ SELL	7,500	31.82	$239K	−4.1%	Form 4 ↗
Sep 17	Sep 17	Brian J. BrilleSee Remarks	See Remarks	▼ SELL	400,000	30.33	$12.1M	−64%	Form 4 ↗
Sep 4	Sep 3	David Baxley SpetzlerPresident	President	▼ SELL	478,000	24.86	$11.9M	−31%	Form 4 ↗
Sep 4	Sep 4	David Baxley SpetzlerPresident	President	▼ SELL	119,212	24.76	$2.95M	−9.2%	Form 4 ↗

Source: SEC Form 4 filings, retrieved Oct 28, 2026. How we read filings

Insiders who traded in the past year

Insider	Role	Bought	Sells	Sold	Latest
John Russel Denton	See Remarks	$0	1	$239K	Sep 23, 2026
Brian J. Brille	See Remarks	$0	1	$12.1M	Sep 17, 2026
David Baxley Spetzler	President	$0	2	$14.8M	Sep 4, 2026

Tracked funds that report CAI

From each fund's latest 13F. Holdings are as of quarter end and are filed up to 45 days later.

Fund	Quarter	Shares	Value	% of portfolio	Change
Coatue Management	Q2 2026	9,819,992	$175.0M	0.36%	No change
Renaissance Technologies	Q2 2026	568,000	$10.1M	0.01%	▲ +26.3%
Duquesne Family Office	Q2 2026	1,894,450	$34K	0.78%	No change

Source: SEC Form 13F-HR filings, retrieved Oct 28, 2026. How we read filings

Reading these numbers

Insiders sell for many reasons: taxes, diversification, a house. Purchases with their own money are rarer and are usually read as more informative. A Form 4 is due within two business days of the trade. How to read a Form 4 →